LeMaitre Corp (LMAT): Earnings per share for the last twelve months

LeMaitre Vascular, Inc. (LMAT) possesses strong pricing power, allowing the company to index product costs without sacrificing demand. Rolling trailing twelve-month earnings per share find support where the parameter value equals 2.69. Direct sales of disposable products ensure stability, although the business is constrained by strict FDA oversight and a potential reduction in elective surgeries during economic downturns.
Analytical breakdowns for LeMaitre Vascular, Inc. (LMAT)

The scaling of implant sales by LeMaitre Vascular, Inc. (LMAT) in Asia and Europe is reflected in the TTM net income per share trend, which currently stands at 2.69. This indicator is calculated as the ratio of total annual net income to the number of shares, eliminating market noise and demonstrating the actual efficiency of profit generation per share of capital to protect the investor from volatility.